Recruiting PHASE1, PHASE2 Tobacco Use

New treatment option for Tobacco Use

Official title Overcoming Nicotine Dependence to Enable Quitting

ClinicalTrials.gov ID: NCT05513872

What this study is testing

What is Nicotine Replacement Therapy (NRT) Sampling?

Nicotine Replacement Therapy (NRT) Sampling is an investigational medicine, being studied as a potential treatment for tobacco use.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
Tobacco use disorder is a chronic, relapsing health condition that necessitates a chronic care approach. However, traditional smoking cessation treatment programs allocate nearly all their resources only to those smokers who are willing to set a quit date.
  • Phase 2: a mid-size study of how well it works

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Eligible participants will be males and females who:
  • are 18 years or older
  • report current daily cigarette smoking (≥ 5 cigarettes per day)
  • are not planning to quit in the next 30 days
  • are not currently engaged in smoking cessation treatment

You likely can't join if

  • Participants will be excluded for daily vaping/ electronic cigarettes use (i.e., use for ≥ 25 days within past 30 days) and any FDA contraindications...
  • are pregnant/breastfeeding
  • had recent cardiovascular trauma such as myocardial infarction
  • had a stroke within the past 3 months
See the full eligibility criteria
Who can join
  • Eligible participants will be males and females who:
  • are 18 years or older
  • report current daily cigarette smoking (≥ 5 cigarettes per day)
  • are not planning to quit in the next 30 days
  • are not currently engaged in smoking cessation treatment
  • are motivated to quit or engage in a non-cessation goal (i.e., reduce smoking, learn more about treatment options, and/ or try out skills to change smoking) in the next 6 months
  • are English speaking
  • reside in the continental United States
  • have access to a smartphone that can be used to complete study procedures
What rules you out
  • Participants will be excluded for daily vaping/ electronic cigarettes use (i.e., use for ≥ 25 days within past 30 days) and any FDA contraindications for NRT use if they:
  • are pregnant/breastfeeding
  • had recent cardiovascular trauma such as myocardial infarction
  • had a stroke within the past 3 months

The study team makes the final eligibility decision.

Where it's taking place

  • Chicago, Illinois, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.